Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

NCT03412630 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

NETWORK

Sponsor class

Stopped poor accrual

Conditions

Recurrent Fallopian Tube Carcinoma
Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma

Interventions

RADIATION: Computed Tomography Perfusion Imaging

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]